Improving Health for Aboriginal People Through Tobacco Related Research
- Conditions
- Tobacco Dependence
- Interventions
- Other: Focus groupOther: One-on-one interviewsOther: Survey
- Registration Number
- NCT01735448
- Lead Sponsor
- The Queen Elizabeth Hospital
- Brief Summary
Aim: To identify barriers and facilitators in the uptake of smoking cessation pharmacotherapies, tobacco prevention, doctor visits, smoking amongst youth, community held health priorities and barriers to research in Aboriginal Australians from the perspectives of:
* Aboriginal smokers and ex/non-smokers
* Aboriginal Healthcare workers
* Consultants/general practitioners, and
* Key stakeholders in Aboriginal health
Focus groups, one-on-one interviews and surveys will be conducted to provide information at the 'grass-roots' level including examinations into perceived differences in locally held beliefs, attitudes, knowledge, traditional practices and the cultural and social constructs, to assist implementation of future tobacco cessation/prevention interventions and treatment of smoking related illnesses. This information can be used to improve the health of Aboriginal people by identifying inadequacies in current practices and highlighting what these are through the eyes of community members, healthcare workers, consultants/general practitioners and key stakeholders. We also intend on examining any facilitators that are identified as positive and working aspects of current initiatives e.g. community infrastructure, in an effort to not 'reinvent the wheel' and acknowledge what is working.
- Detailed Description
We will identify barriers and facilitators for the implementation of smoking cessation pharmacotherapies, tobacco prevention, doctor visits, youth and smoking, community held health priorities and barriers to research through:
1. Multiple focus groups held within 2 communities with Aboriginal smokers and ex/non-smokers, and
2. Focus groups with healthcare workers serving these communities, and
3. Qualitative one-on-one interviews with key stakeholders in Aboriginal communities
4. Qualitative one-on-one interviews with specialists/doctors working with Aboriginal patients
5. Surveys with all participants mentioned above
6. Surveys with specialist groups including members of tobacco related special interest groups of the Thoracic Society of Australia and New Zealand (TSANZ)
Smoking cessation is one of the most important ways to improve the prognosis of patients with respiratory diseases. Despite being over represented in the burden of smoking related morbidity and mortality, very little methodologically rigorous research has been conducted to evaluate and/or enhance the uptake of smoking cessation pharmacotherapies and smoking prevention for Aboriginal Australians, as evident in our two recent (2012) Cochrane meta-analyses and through extensive consultation over the past two years with Aboriginal Elders, key stakeholders, researchers and experts throughout Australia. Moreover, many of the healthcare workers and some doctors on the frontline are reporting that they do not believe they have the skills or ability to offer smoking cessation/prevention initiatives to these patients, and perhaps more importantly, admit to the attitude of 'even if I did, it's not going to work, so why bother'.
In light of this gap in knowledge, our project relates specifically to understanding and improving the lung health of Aboriginal Australians, the cohort with the greatest burden of disease and lowest life expectancy, through qualitative analyses. A total of 10 focus groups, 30 one-on-one interviews and approximately 120 surveys (unless data saturation is reached sooner) will be carried out in collaboration with Aboriginal community involvement. The information obtained from these will provide an overall picture of the barriers and enablers from the perspectives of the various individuals involved, being:
* Aboriginal participants from urban, regional and rural cohorts (8 focus groups plus surveys)
* Aboriginal healthcare workers from urban, regional and rural cohorts (2 focus groups plus surveys)
* Respiratory consultants who see Aboriginal patients (10 one-on-one interviews plus surveys)
* Key stakeholders in Aboriginal health including Aboriginal liaison officers, Aboriginal health councils, Elders \& influential figures in communities (10 one-on-one interviews plus surveys)
* Medical Consultants who see Aboriginal patients (2 one-on-one interviews plus surveys from each of the following disciplines: General Practitioners, cardiology, neurology, oncology and vascular; total of 10, or until data saturation)
Triangulation will occur at multiple levels to improve credibility and dependability including: data collection (focus groups, interviews and surveys), investigators (minimum five investigators involved throughout various aspects of the study), data sources (multiple locations, communities and venues), analysis methods (Grounded theory and Triandis model of behavioural change).
In addition a detailed audit trail will be kept and all focus groups and interviews will undergo feedback (confirmation of accuracy and interpretation) by participants. Quasi-statistics will also be employed as part of the analysis methods.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Male Smokers
- Willing to participate
- Identifies as an Aboriginal person
- Uses more than 10 cigarettes or cigarette equivalent per week
- Has lived in the relevant community for >12 months
Female Smokers
- Willing to participate
- Identifies as an Aboriginal person
- Uses more than 10 cigarettes or cigarette equivalent per week
- Has lived in the relevant community for >12 months
Male Non/Ex Smokers
- Willing to participate
- Identifies as an Aboriginal person
- Has not used tobacco for >3 months
- Has lived in the relevant community for >12 months
Female Non/Ex Smokers
- Willing to participate
- Identifies as an Aboriginal person
- Has not used tobacco for >3 months
- Has lived in the relevant community for >12 months
Healthcare worker
- Willing to participate
- Has provided healthcare to people from Aboriginal people for at least 25% of employment hours over the past 12 months, or
- Has provided healthcare to people from Aboriginal people for at least 5 years of their working career
- Is a qualified healthcare worker
GP's / Specialists
- Willing to participate
- Has provided clinical care to people from Aboriginal people over a 12 month period (at least one consult per week or equivalent)
- Is a qualified General Practitioner or,
- Is a qualified doctor specialising in one of the following disciplines: respiratory, vascular, neurology, oncology, cardiology
Key Stakeholders
- Willing to participate
- Currently working/has worked in Aboriginal health as a primary focus of the position, or
- Is a community Elder, or
- Is influential in Aboriginal health/communities
- Cannot speak English
- Cannot sign a consent
- Does not have the intellectual capacity required to respond to questions
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Aboriginal smoker, male, Adelaide Focus group Focus group: Aboriginal smoker, male from Adelaide Aboriginal smoker, male, Adelaide Survey Focus group: Aboriginal smoker, male from Adelaide Aboriginal smoker, female, Adelaide Focus group Focus group: Aboriginal smoker, female, from Adelaide Healthcare workers, Murray Bridge Survey Focus group: Healthcare workers who are based in Murray Bridge and work with Aboriginal patients Aboriginal ex/non-smoker, male, Murray Bridge Focus group Focus group: Aboriginal ex/non-smoker, male, from Murray Bridge Aboriginal ex/non-smoker, male, Murray Bridge Survey Focus group: Aboriginal ex/non-smoker, male, from Murray Bridge Consultants and General Practitioners One-on-one interviews One-on-one interviews with 10 consultants and/or GP's Aboriginal ex/non-smoker, male, Adelaide Survey Focus group: Aboriginal ex/non-smoker, male, from Adelaide Healthcare workers, Adelaide Survey Focus group: Healthcare workers who are based in Adelaide and work with Aboriginal patients Aboriginal smoker, male, Murray Bridge Survey Focus group: Aboriginal smoker, male, from Murray Bridge Aboriginal smoker, female, Murray Bridge Focus group Focus group: Aboriginal smoker, female, from Murray Bridge Respiratory physicians Survey One-on-one interviews with 10 Respiratory physicians Key community stakeholders One-on-one interviews One-on-one interviews with 10 key Aboriginal community stakeholders Key community stakeholders Survey One-on-one interviews with 10 key Aboriginal community stakeholders Consultants and General Practitioners Survey One-on-one interviews with 10 consultants and/or GP's Aboriginal smoker, female, Adelaide Survey Focus group: Aboriginal smoker, female, from Adelaide Aboriginal ex/non-smoker, female, Adelaide Focus group Focus group: Aboriginal ex/non-smoker, female, from Adelaide Healthcare workers, Adelaide Focus group Focus group: Healthcare workers who are based in Adelaide and work with Aboriginal patients Healthcare workers, Murray Bridge Focus group Focus group: Healthcare workers who are based in Murray Bridge and work with Aboriginal patients Aboriginal smoker, female, Murray Bridge Survey Focus group: Aboriginal smoker, female, from Murray Bridge Aboriginal ex/non-smoker, female, Murray Bridge Survey Focus group: Aboriginal ex/non-smoker, female, from Murray Bridge Respiratory physicians One-on-one interviews One-on-one interviews with 10 Respiratory physicians Aboriginal ex/non-smoker, male, Adelaide Focus group Focus group: Aboriginal ex/non-smoker, male, from Adelaide Aboriginal ex/non-smoker, female, Adelaide Survey Focus group: Aboriginal ex/non-smoker, female, from Adelaide Aboriginal smoker, male, Murray Bridge Focus group Focus group: Aboriginal smoker, male, from Murray Bridge Aboriginal ex/non-smoker, female, Murray Bridge Focus group Focus group: Aboriginal ex/non-smoker, female, from Murray Bridge
- Primary Outcome Measures
Name Time Method Determine the barriers and facilitators to pharmacological initiatives for tobacco cessation in Aboriginal populations 18 months Qualitative analysis (focus groups, one-on-one interviews and surveys). The use of pharmacotherapies for smoking cessation significantly improves the probability of successful abstinence. Identification of the barriers and facilitators for tobacco cessation pharmacotherapies will be determined through these qualitative discussions and mixed method approaches
- Secondary Outcome Measures
Name Time Method Identify barriers and facilitators to research initiatives in Aboriginal people and identify self-reported health priorities 18 months Qualitative analysis (focus groups, one-on-one interviews and surveys). Research in Aboriginal populations are often lengthy and in many cases fail to achieve their objectives, often due to inappropriate methodology or a lack of consultation with Aboriginal Elders or key stakeholders research initiatives particularly related to tobacco and chronic illnesses will be determined through these qualitative discussions and mixed method approaches. In addition, we aim to identify health priorities identified by participants within the focus groups, one-on-one interviews and surveys that can be targeted for future research initiatives.
Determine the barriers and facilitators for tobacco prevention initiatives, particularly related to Aboriginal youth 18 months Qualitative analysis (focus groups, one-on-one interviews and surveys). The use of tobacco prevention initiatives significantly improves the probability of lower tobacco prevalence long-term. Identification of the barriers and facilitators for tobacco prevention initiatives will be determined through these qualitative discussions and mixed method approaches
Identify the barriers and facilitators for doctor visits by Aboriginal people 18 months Qualitative analysis (focus groups, one-on-one interviews and surveys). Regular doctor visits by Aboriginal people can significantly reduce the progression of chronic illnesses, improve quality of life and reduce health care costs. Identification of the barriers and facilitators for these doctor visits, particularly with Respiratory physicians, will be determined through these qualitative discussions and mixed method approaches
Trial Locations
- Locations (3)
Murray Mallee Community Health Service; Aboriginal Primary Health Care Unit
🇦🇺Murray Bridge, South Australia, Australia
The Basil Hetzel Institute for Translational Health Research
🇦🇺Adelaide, South Australia, Australia
The Queen Elizabeth Hospital
🇦🇺Adelaide, South Australia, Australia